Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Cellulitis, Impaired work ability, Joint swelling
Clinical narrative: thought it was cellulitis; 3 days after 2nd dose left ankle swelled up; was out of work for 4 months after 2nd Moderna dose; was in so much pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of CELLULITIS (thought it was cellulitis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CELLULITIS (thought it was cellulitis) (seriousness criterion medically significant), JOINT SWELLING (3 days after 2nd dose left ankle swelled up), PAIN (was in so much pain) and ARTHRALGIA (Joint pain). an unknown date, the patient experienced IMPAIRED WORK ABILITY (was out of work for 4 months after 2nd Moderna dose). At the time of the report, CELLULITIS (thought it was cellulitis), JOINT SWELLING (3 days after 2nd dose left ankle swelled up), IMPAIRED WORK ABILITY (was out of work for 4 months after 2nd Moderna dose), PAIN (was in so much pain) and ARTHRALGIA (Joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: abnormal (abnormal) bloodwork out of whack, nothing in range.         No concomitant medication were reported.  Treatment medication included Antibiotics. The patient was out of work for 4 months after second Moderna dose. Patient stated that three days after second dose left ankle swelled up, doctors thought it was cellulitis, was in so much pain. The blood work was out of whack, nothing in range. Patient also experienced joint pain which was a side effect always experienced.  Company Comment: This case concerns a female patient of an unknown age, with no reported medical history, who experienced the unexpected events of Cellulitis, Joint swelling, Impaired work ability, Pain and the expected event of Arthralgia. The events occurred approximately 3 days after the second dose of mRNA-1273 Vaccine. At the time of the report the outcome of the events was unknown. The rechallenge is not applicable since no further dosing is expected. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This case concerns a female patient of an unknown age, with no reported medical history, who experienced the unexpected events of Cellulitis, Joint swelling, Impaired work ability, Pain and the expected event of Arthralgia. The events occurred approximately 3 days after the second dose of mRNA-1273 Vaccine. At the time of the report the outcome of the events was unknown. The rechallenge is not applicable since no further dosing is expected. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.